Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diprovocims: a new and potent class of TLR agonists

Diprovocims: a new and potent class of TLR agonists

US Patent 11040959 · Granted Jun 22, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for cancer therapy2022
Ultra-potent vinca alkaloids: added molecular complexity further disrupts the tu2021
Peripheral modifications on pocket-redesigned vancomycin analogs synergistically2021
Vinblastine 20″ amides: synthetic analogs that maintain or improve potency and s2020
N-(hydrophobe-substituted) vancosaminyl [Ψ-[C(=NH) NH] Tpg4] vancomycin and [Ψ-[2020
Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and me2019
Pyrazole compounds and methods of making and using same2018
TLR-independent small molecule adjuvants2018
TLR-independent small molecule adjuvants2018
Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial2018
Neoseptins: small molecule adjuvants2017
Neoseptins: small molecule adjuvants2017